Post Approval Changes in Biologics Manufacturing
Available since March 2020
Janmeet Anant, Ph.D & Guido Kremer-van der Kamp (Merck)
This is a practical assessment guide on a Post-Approval Changes analysis from the supplier’s perspective on the real regulatory constraints and intents, with support of benefit-risk case studies in vaccine manufacturing.